CYP19A1 and Alzheimer disease: Thus, it has been reported that some CYP19A1 polymorphisms, either per se107–112 or in combination with polymorphisms for other genes,113,114 are associated with increased AD susceptibility, whereas other aromatase gene polymorphisms may decrease AD risk.115